Zilver PTX G38486Recalls & reported problems
Cook Ireland Ltd · Zilver PTX, Drug-Eluting Peripheral Stent · Class 3 · Implant
All models of Zilver PTX (28)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 10827002384863), received between Aug 22, 2017 and Feb 26, 2020 — classified as 5 malfunctions.
The most frequently reported specific device problem is “Delivery System Failure” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Delivery System Failure1
- Difficult to Remove1
- Expiration Date Error1
- Fracture1
- Use of Device Problem1
Patient problems
- No Known Impact Or Consequence To Patient3
- No Consequences Or Impact To Patient2
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionFeb 26, 2020Expiration Date Error; Expiration Date Error
EXPIRED ZILVER PTX PLACED IN PATIENT. NO ISSUES DURING THE PROCEDURE. NO ADVERSE EFFECTS REPORTED. NO ADDITIONAL INTERVENTIONS NEEDED. THE PHYSICIAN PUT THE PATIENTS ON ANTIBIOTICS AFTER THE CASE BECAUSE HE WAS WORRIED ABOUT THE STERILITY OF THE STENT. PATIENT HAD NO ISSUES AT TIME OF/IMMEDIATELY AFTER PROCEDURE. FACILITY WILL NOT BE REPORTING TO THE FDA.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 9755900 ↗MalfunctionJul 26, 2019Fracture; Fracture
AS REPORTED TO CUSTOMER RELATIONS, "UPON DEPLOYING THE STENT AND WITHDRAWING THE DELIVERY SYSTEM FROM THE SHEATH, RESISTANCE WAS MET AND THE DISTAL END OF THE STENT DELIVERY SYSTEM APPEARED TO BREAK OFF."
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8829801 ↗MalfunctionApr 2, 2019Use of Device Problem; Use of Device Problem
AS REPORTED TO CUSTOMER RELATIONS: "PHYSICIAN SAID HE STARTED ADVANCING THE ZILVER PTX OVER THE BENTSON WIRE AND FELT RESISTANCE AS IT WAS GOING OVER THE WIRE AND THRU THE SHEATH. HE SAID HE GOT IT ABOUT 4-5 CM BEFORE WHERE HE NEEDED TO DEPLOY THE STENT AND IT WOULDN'T ADVANCE ANY FURTHER. HE TRIED REMOVING IT AND WAS HAVING A DIFFICULT TIME. HE FINALLY PULLED THE ZILVER PTX DELIVERY CATHETER ALONG WITH THE BENTSON WIRE OUT OF THE PATIENT. HE LOST ACCESS, BUT GOT THE WIRE BACK TO THE CELIAC AND OPENED ANOTHER 7X40 ZILVER PTX. THAT ONE DEPLOYED WITHOUT AND COMPLICATIONS AND THERE WAS NO RESISTANCE GOING OVER THE WIRE. THE PATIENT WAS NOT HARMED DURING THIS PROCEDURE." ADDITIONAL INFORMATION PROVIDED BY CUSTOMER OVER THE PHONE ON 02APR2019: "IMAGERY WILL NOT BE MADE AVAILABLE."
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8474337 ↗MalfunctionMar 20, 2018Delivery System Failure; Delivery System Failure
INITIAL MDR IS BEING SUBMITTED BASED ON THE DEVICE MALFUNCTION PRECEDENCE: ¿THUMBWHEEL MALFUNCTIONS DURING DEPLOYMENT¿". AS REPORTED TO CUSTOMER RELATIONS, "THE THUMBWHEEL STOPPED WORKING. THE PROCEDURE WAS COMPLETED WITH THE COMPLAINT DEVICE."
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7352850 ↗MalfunctionAug 22, 2017Difficult to Remove; Difficult to Remove
THIS INITIAL REPORT IS BEING SUBMITTED DUE TO THE MALFUNCTION PRECEDENCE: "DELIVERY SYSTEM CANNOT BE WITHDRAWN". THIS REPORT FORMS PART OF RETROSPECTIVE REVIEW OF OPEN COMPLAINTS FOR A NEW MALFUNCTION PRECEDENCE FOR THIS DEVICE FAMILY. BALKIN SHEATH WAS UP AN OVER THE AORTIC BIFURCATION, STIFF .035 WIRE WAS DOWN THE CONTRA-LATERAL SFA, PRE-DIL OCCURRED AND PHYSICIAN DECIDED TO PLACE STENT. STENT WAS DIFFICULT TO TRACK TO LESION, DEPLOYED FINE, AND COULD NOT BE REMOVED SO WIRE AND CATHETER HAD TO BE REMOVED TOGETHER.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6810634 ↗
Other Stent, superficial femoral artery, drug-eluting devices
- ELUVIA™ H74939294601210Boston Scientific Corporation · Stent, superficial femoral artery, drug-eluting1 death80 reports
- Zilver PTX G24890Cook Ireland Ltd · Stent, superficial femoral artery, drug-eluting1 recall24 reports
- ELUVIA™ H74939294701210Boston Scientific Corporation · Stent, superficial femoral artery, drug-eluting58 reports
- Zilver PTX G38482Cook Ireland Ltd · Stent, superficial femoral artery, drug-eluting57 reports
- Zilver PTX G24895Cook Ireland Ltd · Stent, superficial femoral artery, drug-eluting1 recall3 reports
- ELUVIA™ H74939294601510Boston Scientific Corporation · Stent, superficial femoral artery, drug-eluting50 reports
- Zilver PTX G38483Cook Ireland Ltd · Stent, superficial femoral artery, drug-eluting32 reports
- ELUVIA™ H74939294701510Boston Scientific Corporation · Stent, superficial femoral artery, drug-eluting31 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page